Camilla Huse Bondesson
Director/Board Member presso GENETIC ANALYSIS
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Povl-André Bang Bendz | M | 62 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 10 anni |
Kenneth Graabek Johansen | M | 48 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 3 anni |
Michael Schaefer | M | - |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 2 anni |
Ole Thastrup | M | 71 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 18 anni |
Ronny Hermansen | M | 62 | 10 anni | |
Sara Mangsbo | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 anni |
Nils Aage Brünner | M | 72 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 4 anni |
Michael Lutz | M | 56 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 4 anni |
Erika Fletcher | F | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 anni |
Fernando Andreu | M | 60 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 3 anni |
Ulrich Karl Walter Spengler | M | 57 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 11 anni |
Margaretha Gadnell | F | 65 |
Conlega AB
Conlega AB Miscellaneous Commercial ServicesCommercial Services Conlega operates as a consulting firm specializing in bio business. Its services include interim management, business coaching, board assignments and commercialization of new products. The company was founded by Paula Zeilon and Margaretha Gadnell in 2001 and is headquartered in Lund, Sweden. | 23 anni |
Eilert Aamodt | M | 54 | 3 anni | |
Simon Hesse Hoffmann | M | 46 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 7 anni |
Thomas Totterman | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 anni |
Grith Hagel | F | 65 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 18 anni |
Paula Zeilon | F | 62 |
Conlega AB
Conlega AB Miscellaneous Commercial ServicesCommercial Services Conlega operates as a consulting firm specializing in bio business. Its services include interim management, business coaching, board assignments and commercialization of new products. The company was founded by Paula Zeilon and Margaretha Gadnell in 2001 and is headquartered in Lund, Sweden. | - |
Kari Furu | M | 44 | 8 anni | |
Justyna Leja-Jarblad | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Mark Gray | M | 54 | 2 anni | |
Manuel Fernández | M | - | 2 anni | |
Jesper Kristiansen | M | 59 | 3 anni | |
Per Matsson | M | 70 | - | |
Andrew Stapleton | M | 68 | - | |
Lars Tiller | M | - | 2 anni | |
Jörgen Lönngren | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Charlotte Leife | F | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Bengt Håkan Englund | M | 72 |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 anni |
Christina Casèn | F | 64 | 15 anni | |
Anne Camilla Huse Bondesson | F | 66 |
Conlega AB
Conlega AB Miscellaneous Commercial ServicesCommercial Services Conlega operates as a consulting firm specializing in bio business. Its services include interim management, business coaching, board assignments and commercialization of new products. The company was founded by Paula Zeilon and Margaretha Gadnell in 2001 and is headquartered in Lund, Sweden. | 20 anni |
Fredrik Lehmann | M | 48 |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Lars Olov Jonsson | M | 72 |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 anni |
Tonni Bülow-Nielsen | M | - | 1 anni | |
Rune Sørum | M | 68 | 14 anni | |
Jørgen Drejer | M | 69 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | 7 anni |
Raphael Gruber | M | 60 | 2 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Michel Klimkeit | M | - | 1 anni | |
Giovanni Magni | M | 67 | - | |
Kathryn Moore Baker | F | 60 | - | |
Tore Grøttum | M | 62 | 1 anni | |
Staffan Strömberg | M | 57 | 3 anni | |
Juan Farré | M | 59 | 2 anni | |
Maarten van der Linden | M | 55 | 4 anni | |
Carit Jacques Andersen | M | 60 | 2 anni | |
Henrik Harling | M | 71 | 3 anni | |
Pia van der Zee | F | - | 1 anni | |
Anita Patel Jusnes | F | 50 | 3 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Svezia | 31 | 65.96% |
Norvegia | 13 | 27.66% |
Danimarca | 11 | 23.40% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Camilla Huse Bondesson
- Contatti personali